BF
Brandon Folkes HC Wainwright & Co. Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
MannKind Corp
MNKD
$1.7B
| $5.54 | $11 |
99%
upside
| Buy |
2 Sep ‘25
5 days ago |
|
2 |
VALN
2
Valneva
VALN
$743M
| $8.65 | $18 |
108%
upside
| Buy |
25 Aug ‘25
13 days ago |
|
3 |
3
Journey Medical
DERM
$184M
| $7.01 | $13 |
85%
upside
| Buy |
25 Aug ‘25
13 days ago |
|
4 |
4
Achieve Life Sciences
ACHV
$145M
| $2.83 | $12 |
324%
upside
| Buy |
21 Aug ‘25
17 days ago |
|
5 |
EPRX
5
Eupraxia Pharmaceuticals
EPRX
$194M
| $5.39 | $12 |
123%
upside
| Buy |
20 Aug ‘25
18 days ago |
|
6 |
GNFT
6
Genfit
GNFT
$197M
| $3.94 | $9 |
128%
upside
| Buy |
19 Aug ‘25
19 days ago |
|
7 |
7
PolyPid
PYPD
$54.8M
| $3.45 | $13 |
277%
upside
| Buy |
13 Aug ‘25
25 days ago |
|
8 |
CNTB
8
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$97.5M
| $1.75 | $7 |
300%
upside
| Buy |
13 Aug ‘25
25 days ago |
|
9 |
9
Xeris Biopharma Holdings
XERS
$1.27B
| $7.85 | $10 |
27%
upside
| Buy |
12 Aug ‘25
26 days ago |
|
10 |
10
Collegium Pharmaceutical
COLL
$1.21B
| $38.32 | $44 |
15%
upside
| Buy |
11 Aug ‘25
27 days ago |
|
11 |
11
ANI Pharmaceuticals
ANIP
$2.07B
| $95.35 | $93 |
2%
downside
| Buy |
8 Aug ‘25
1 month ago |
|
12 |
12
CorMedix
CRMD
$926M
| $12.40 | $17 |
37%
upside
| Buy |
8 Aug ‘25
1 month ago |
|
13 |
13
Sagimet Biosciences
SGMT
$231M
| $7.11 | $29 |
308%
upside
| Buy |
7 Aug ‘25
1 month ago |
|
14 |
14
Indivior
INDV
$3.12B
| $24.98 | $28 |
12%
upside
| Buy |
6 Aug ‘25
1 month ago |
|
15 |
15
Enanta Pharmaceuticals
ENTA
$189M
| $8.85 | $20 |
126%
upside
| Buy |
28 Jul ‘25
1 month ago |
|
16 |
16
Zevra Therapeutics
ZVRA
$502M
| $8.95 | $26 |
191%
upside
| Buy |
2 Jul ‘25
2 months ago |
|
17 |
17
Heron Therapeutics
HRTX
$201M
| $1.31 | $6 |
358%
upside
| Buy |
9 Jun ‘25
3 months ago |
|
18 |
18
Milestone Pharmaceuticals
MIST
$153M
| $1.80 | $5 |
178%
upside
| Buy |
5 Jun ‘25
3 months ago |
|
19 |
CRDL
19
Cardiol Therapeutics
CRDL
$91.3M
| $1.09 | $9 |
726%
upside
| Buy |
2 Jun ‘25
3 months ago |
|
20 |
20
Trevi Therapeutics
TRVI
$854M
| $7.01 | $21 |
200%
upside
| Buy |
28 May ‘25
3 months ago |
|
21 |
21
Rockwell Medical
RMTI
$55.8M
| $1.62 | $5 |
209%
upside
| Buy |
14 Nov ‘24
9 months ago |
|
22 |
22
Achieve Life Sciences
ACHV
$145M
| $2.83 | $12 |
324%
upside
| Buy |
14 Nov ‘24
9 months ago |
|
23 |
EPRX
23
Eupraxia Pharmaceuticals
EPRX
$194M
| $5.39 | $9 |
67%
upside
| Buy |
14 Nov ‘24
9 months ago |
|
24 |
24
Omeros
OMER
$284M
| $4.17 | $9 |
116%
upside
| Buy |
14 Nov ‘24
9 months ago |
|
25 |
ADIL
25
Adial Pharmaceuticals
ADIL
$7.61M
| $0.3485 | $8 |
2,196%
upside
| Buy |
14 Nov ‘24
9 months ago |
|